When is the next recession?

Equity analyst Laura Nelson Carney uses her PhD in neuroscience to help spot medical innovation around the world. She brings a deep understanding of science to health care investing, using her research and drug development experience to help identify breakthrough drugs. And today ...  Show more

Brittain Ezzes, a portfolio manager for Capital Group Dividend Value ETF, shares her perspective on an unexpected rally this year among heavy-asset companies, or companies outside of AI and big tech. She offers three catalysts that could sustain the rally, identifies areas where ...  Show more

Bloomberg Opinion columnist Barry Ritholtz speaks with Scott Sperling, who is co-CEO of private equity firm Thomas H. Lee Partners (THL), and a member of the firm’s management and investment committees. He previously spent more than a decade as managing partner of the affiliate o ...  Show more

Bloomberg Opinion columnist Barry Ritholtz speaks with Jeff Immelt, who is a venture partner at the global venture capital and private equity firm New Enterprise Associates (NEA). Prior to joining NEA in 2018, Jeff was the ninth chairman of GE and served as chief executive office ...  Show more

While challenges remain in the near term, leaders of the country’s top banks agree that a rebound is likely on the horizon, with vaccines playing an ever-important role. What other factors are impacting Canada’s financial sector? Stu Kedwell, Co-Head, North American Equities, rec ...  Show more

Our guest this week is Dr. Burton Malkiel. Dr. Malkiel is the Chemical Bank chairman's professor of economics at Princeton University. And he's also author of the widely influential investment book, "A Random Walk Down Wall Street." He's also the Chief Investment Officer at We ...